Rm. Kliegman, NEONATAL TECHNOLOGY, PERINATAL SURVIVAL, SOCIAL-CONSEQUENCES, AND THEPERINATAL PARADOX, American journal of public health, 85(7), 1995, pp. 909-913
Exogenous surfactant therapy for premature infants with respiratory di
stress syndrome has had a significant impact on infant mortality and o
n some complications of prematurity. Yet the total number of low-birth
weight infants has not declined, resulting in a high-risk population w
ho would require surfactant therapy and long-term child care. Survivin
g low-birthweight infants (despite surfactant therapy) remain at risk
for the consequences of premature birth, such as neurosensory impairme
nt, cerebral palsy, and chronic lung disease. In addition, because of
the close association between poverty and low birthweight, surviving p
remature infants are at increased risk for the new morbidities such as
violence, homelessness, child abuse and neglect, and addictive drug u
se. A goal should be to reduce the risk of being born with a low birth
weight, rather than having to treat the consequences of premature gest
ation. Despite the marvelous advances that permit us to treat respirat
ory distress syndrome, the continuing high low-birthweight rate places
a significant strain on our health care system. The goal should be re
directed to identifying large population-based efforts to reduce the n
umber of low-birthweight infants.